1st Quarter - Report — SOCIETY FOR CARDIOVASCULAR ANGIOGRAPHY… for SOCIETY FOR CARDIOVASCULAR ANGIOGRAPHY… (2017)

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm

SOCIETY FOR CARDIOVASCULAR ANGIOGRAPHY AND INTERVENTIONS

Client

SOCIETY FOR CARDIOVASCULAR ANGIOGRAPHY AND INTERVENTIONS

Income

—

Expenses

$30,000

Expense method

A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing	Filed	Amount	Counted
1st Quarter - Report (this page)	Aug 7, 2017	$30,000	Replaced
1st Quarter - Amendment	Nov 6, 2017	$20,000	Yes

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

physician payment

Lobbyist	Covered position, as disclosed
JOEL CHRISTOPHER HARDER	—

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE

Health Issues HCR

Medicare healthcare reform and FDA issues

Lobbyist	Covered position, as disclosed
JOEL CHRISTOPHER HARDER New	—

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE

Medical/Disease Research/Clinical Labs MED

coverage and payment for physician services

Lobbyist	Covered position, as disclosed
JOEL CHRISTOPHER HARDER	—

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.